Skip to main content
Go back to Resources
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population
Authors:
Volume:
Pagination:
Issue:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients
Authors:
Volume:
Pagination:
Issue:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis
Authors:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
Authors:
Volume:
Pagination:
Issue:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Authors:
Volume:
Pagination:
Journal:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®
Authors:
Volume:
Pagination:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)
Authors:
Pagination:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Authors:
Journal:
PMID:
URL:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
CureAA - A Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) #2207
Authors:
Location:
URL:
Go back to Resources
Go back to Resources
Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis
Authors:
Location:
URL:
Go back to Resources